MYGN 15.49 (+2.45%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

43 / 56

Dividend yield

0 / 9

Total Cash

36 / 57

Performance 3 years

27 / 58

Performance 5 years

34 / 58

Performance 10 years

36 / 58

Linearity 3 years

20 / 58

Linearity 5 years

23 / 58

Linearity 10 years

13 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Linearity 5 years - MYGN ranking 23 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by linearity 5 years
1. Qiagen QGEN
158.02
2. Co-Diagnostics CODX
79.18
3. CareDx CDNA
45.54
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. DarioHealth DRIO
31.71
6. Syneos Health SYNH
24.79
7. Inotiv NOTV
17.48
8. Heska HSKA
15.42
9. Fulgent Genetics FLGT
13.92
10. DexCom DXCM
10.69
11. Anixa Biosciences ANIX
9.46
12. Charles River Laboratories CRL
9.26
13. Olink Holding OLK
8.53
14. Icon ICLR
8.41
15. Pacific Biosciences of California PACB
7.93
16. IQVIA Holdings IQV
7.29
17. Exact Sciences EXAS
6.44
18. Bioventus BVS
6.03
19. Aspira Womens Health AWH
5.9
20. NeoGenomics NEO
5.81
21. Interpace Biosciences IDXG
5.61
22. Twist Bioscience TWST
5.39
23. Myriad Genetics MYGN
5.14
24. Trinity Biotech TRIB
5.09
25. PerkinElmer PKI
4.97
26. Personalis PSNL
4.88
27. IDEXX Laboratories IDXX
4.53
28. Mettler-Toledo MTD
4.24
29. Thermo Fisher Scientific TMO
4.1
30. Agilent Technologies A
3.97
31. Illumina ILMN
3.97
32. Neogen NEOG
3.89
33. Guardant Health GH
3.77
34. Quest Diagnostics DGX
3.69
35. Sotera Health SHC
3.69
36. Sera Prognostics SERA
3.65
37. Enzo Biochem ENZ
3.59
38. Laboratory Corp of America Holdings LH
3.47
39. Danaher DHR
3.23
40. Waters WAT
3.08
41. National Research NRC
2.92
42. Psychemedics PMD
2.65
43. Precipio PRPO
2.51
44. Exagen XGN
2.31
45. Neuronetics STIM
2.28
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
2.06
48. MaxCyte MXCT
2.01
49. Biodesix BDSX
1.91
50. bioAffinity Technologies BIAF
1.89
51. Prenetics Global PRE
1.81
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.59
56. Medpace Holdings MEDP
0.56
57. Lantheus Holdings LNTH
0.52
58. RadNet RDNT
0.34
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.